Pasteur said "Chance favors the prepared mind." In that spirit, we continue preparing our collaboration with the NIH for their Phase 2 trial with our universal flu vaccine. We're also looking forward to results from our Phase 2b in Europe.
Please keep reading for more recent news. As always, we welcome your feedback.
I hope you're having a wonderful summer!
- Ron Babecoff, President and CEO
Another compelling justification for BiondVax's universal flu vaccine: Mounting evidence indicates the tropics experience unique annual flu patterns including multiple peaks, and mixed north and south strains. [Hirve et al, Plos]
Certain statements contained in this email, and in content linked to from this email, are forward-looking statements which involve known and unknown risks, uncertainties, and other factors which may cause the actual results, performance or achievements of BiondVax Pharmaceuticals Ltd. ("the Company"), or industry results, to be materially different from any results performance or achievement expressed or implied by such forward-looking statements. Please refer to the Company’s filing with the Security and Exchange Commission for a comprehensive list of risk factors that could cause actual results, performance or achievements of the Company to differ materially from those expressed or implied in such forward-looking statements. The Company undertakes no obligation to update or revise any forward-looking statements.